- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03928457
Impact of Chronic Exposure to Radiofrequency Electromagnetic Fields on Neurophysiological Development in the Preterm Neonate (NeuroPrem-RF)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Preterm infants are potentially exposed to chronic, low levels of electromagnetic fields, especially radiofrequencies, while hospitalized in neonatal intensive care units. Moreover, they may be particularly vulnerable due to increased penetration of radiofrequency waves into the brain during a crucial period of neurodevelopment. This study will aim at evaluating the influence of radiofrequency electromagnetic fields exposure on the neurophysiological development in preterm neonates.
The first part of this study will be devoted to the measurement of environmental electromagnetic fields in order to map their distribution in the paediatric department. From birth and during 6 weeks, the investigators will perform, for each child, a continuous measurement of radiofrequencies at the incubator level. Infants' clinical data (medical history, nutrition, morphology...) and the evolution of the thermal environment in incubators (air and body temperatures) will also be continually monitored. At 3 and 6 weeks of life, the investigators will investigate sleep (EEG, EOG), cerebral hemodynamics (near-infrared spectroscopy), autonomic nervous system activity (ECG, heart rate variability) and various cardiorespiratory parameters (SpO2, apnoea, bradycardia) thanks to a night-time polysomnography.
The impact of radiofrequency electromagnetic fields will be evaluated by analyses of the relationship between exposure levels and the various parameters extracted from the neurophysiological investigation phase.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cécile Fontaine, MD
- Phone Number: (33)322087608
- Email: fontaine.cecile@chu-amiens.fr
Study Locations
-
-
-
Amiens, France, 80054
- CHU Amiens
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- preterm neonates born at 26 to 34 weeks of gestational age
- signed written informed consent form
Exclusion Criteria:
- infants infected
- infants suffering from neurological disorders
- serious heart, respiratory, digestive or metabolic diseases
- infants born from mothers aged less than 18 years old or deprived of their parental rights
- non covered by national health insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: preterm neonate
|
Parental questionnaire on pregnancy history and environmental exposure
Daily continuous recording of radiofrequency exposure levels (6 weeks) by placing a dosimeter inside the incubator
Follow-up of daily infants environmental and clinical parameters: morphological characteristics, drugs, ventilatory support, dietary management, clinical outcomes, incubator data (temperatures…)
Nocturnal polysomnography (at 3 and 6 weeks of life, between 8 pm and 8 am) with recording of sleep (electroencephalography, electrooculography),
cerebral hemodynamics (near infrared spectroscopy)
activity of the autonomic nervous system (electrocardiography, analysis of heart rate variability)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
total sleep time in hours
Time Frame: from birth to 6 weeks of life
|
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
|
from birth to 6 weeks of life
|
absolute durations of sleep states in hours
Time Frame: from birth to 6 weeks of life
|
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
|
from birth to 6 weeks of life
|
relative durations of sleep states in hours
Time Frame: from birth to 6 weeks of life
|
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
|
from birth to 6 weeks of life
|
sleep state change frequency
Time Frame: from birth to 6 weeks of life
|
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
|
from birth to 6 weeks of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cerebral hemodynamics
Time Frame: from birth to 6 weeks of life
|
Cerebral hemodynamics will be determined by measuring regional cerebral oxygen saturation
|
from birth to 6 weeks of life
|
Autonomic nervous system activity
Time Frame: from birth to 6 weeks of life
|
Autonomic nervous system activity will be determined by measuring means of a heart rate variability
|
from birth to 6 weeks of life
|
apnea frequency
Time Frame: from birth to 6 weeks of life
|
cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined
|
from birth to 6 weeks of life
|
bradycardia frequency
Time Frame: from birth to 6 weeks of life
|
cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined
|
from birth to 6 weeks of life
|
desaturation frequency
Time Frame: from birth to 6 weeks of life
|
cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined
|
from birth to 6 weeks of life
|
Evolution of the anthropomorphic characteristics of the subjects
Time Frame: from birth to 6 weeks of life
|
anthropomorphic characteristics of the subjects are height and weight.
Weight and height will be combined to report BMI in kg/m^2.
|
from birth to 6 weeks of life
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pierre Tourneux, Pr, CHU Amiens
- Principal Investigator: François Moreau, MD, CHU Amiens
- Principal Investigator: Lucie Aimée Razafimanantsoa, MD, CHU Amiens
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2018_843_0033
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Infant
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedPreterm Infant Development | Preterm Infant Health
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
Medical University of GrazCompleted
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
University of OxfordShoklo Malaria Research UnitCompleted
-
yangjieCompletedOutcome, Fatal | Preterm Infant | Morbidity;Infant
-
Medical University of GrazCompletedIntubation; Difficult or Failed | Preterm Infant | Term InfantAustria
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
IWK Health CentreRecruitingPreterm InfantCanada
Clinical Trials on Parental questionnaire
-
University Hospital, CaenCompletedNeurodevelopmental Disorders | Child BehaviorFrance
-
Ankara Yildirim Beyazıt UniversityCompletedDental Caries | Dental Anxiety | Children, OnlyTurkey
-
Tel Aviv UniversityCompleted
-
University Hospital, MontpellierCompletedInfant DevelopmentFrance
-
Institut National de la Santé Et de la Recherche...RecruitingPatency of the Ductus Arteriosus Acetaminophen Extreme PrematurityFrance
-
University Hospital Inselspital, BerneCompletedPreterm Infants | Parents | Procedural PainSwitzerland
-
University GhentCompletedDevelopmental Coordination DisorderBelgium
-
Université Catholique de LouvainSuspendedDeaf Nonspeaking, Not Elsewhere ClassifiedBelgium
-
Paediatric Neuroimaging Research GroupUniversity of Oxford; Wellcome Trust; BLISS charityCompleted
-
Central Hospital, Nancy, FranceCompleted